Now I have enough data. Let me analyze the anchors and finalize my review.

**Key anchors:**
- JQtuCumAFD.md (5.50, ACCEPTED) — the closest prior work (Davidov et al., 2025). This is the paper the submission directly extends. It had polarized reviews (3,8,8,3) and was criticized for incremental contributions and PAC-type guarantee.
- Nfd7z9d6Bb.md (6.00, ACCEPTED) — CP extension achieving approximately conditional coverage. Consistent 6s.
- AKAz88zYLB.md (5.80, REJECTED) — Conformal prediction for dose-response. Conservative intervals, only synthetic data.
- pVL4bYKOGM.md (5.50, REJECTED) — CP for causal effects of continuous treatments. Weak evaluation.
- 33XGfHLtZg.md (7.00, ACCEPTED) — Conformal Risk Control. Foundational CP extension with broad applications.
- RcNzwKrjTo.md (5.00, REJECTED) — CP for improved conditional coverage via trust scores.
- uUkpYafkVl.md (4.75, REJECTED) — CP for deep classifiers via truncating.

**Round 1 bracket:** The paper is clearly better than JQtuCumAFD (scored 5.50, accepted) because it improves the guarantee from PAC to exact (with explicit error term), adds doubly robustness, and provides better empirical validation. But it's less foundational than Conformal Risk Control (7.00). The τ-optimization gap holds it back from 7+. Bracket: **6.0–7.0**.

The paper directly improves upon the accepted prior work (JQtuCumAFD, 5.50) with a stronger theoretical guarantee and better robustness, placing it above 5.50. The τ-optimization gap is a genuine structural issue that keeps it below 7.0 (the Conformal Risk Control level). Final score: **6.5**.

---

## Summary
This paper proposes a weighted conformal prediction procedure for constructing lower prediction bounds (LPBs) for counterfactual survival times under different treatments in the general right-censored data setting. The key idea is to reweight non-conformity scores using importance weights (density ratios) that correct for covariate shift between the marginal population and the treated-uncensored subpopulation, yielding an explicit coverage guarantee with quantifiable error from weight estimation (Theorem 4.1) and a doubly robust asymptotic guarantee (Theorem 4.2). Experiments on synthetic data (6 settings) and a real lung cancer dataset (541 patients) demonstrate validity and informativeness.

## Strengths
- **Well-motivated theoretical advance over prior work**: The paper identifies a concrete limitation of existing conformal prediction methods for survival data — PAC-type guarantees that may not cover extreme cases — and provides a principled solution via weighted conformal prediction. The reformulation in equation (1) transforms the coverage probability into a reweighted expectation, avoiding the empirical averaging approximation that limits prior work (Gui et al., 2024; Davidov et al., 2025). Theorem 4.1 (equation 4) bounds the coverage gap by ½ E[|ω̃(X) − ω(X)|], making the "well-estimated weights" assumption precise.
- **Doubly robust asymptotic property**: Theorem 4.2 guarantees asymptotic coverage when either the weight function γ(x) or the conditional quantile estimator is consistently estimated. This mutual compensation mechanism (conditions A1 and A2) provides practical resilience to model misspecification — a genuine theoretical asset for deployment.
- **Maintained coverage under outlier contamination**: Figure 3 demonstrates that under outlier scenarios (Normal noise applied to 10% of data), the proposed method maintains coverage near 90% nominal level while FOCUS and FUSED methods (Davidov et al., 2025) with only PAC-type guarantees break down. This is direct empirical evidence that the exact guarantee translates to practical reliability advantages.
- **Clinically interpretable real-data validation**: Figures 4–5 on 541 NSCLC patients show LPBs that correlate with known clinical evidence (VMAT > IMRT per Hunt et al., 2022; induction/concurrent chemotherapy benefits per Curran et al.; Aguado et al., 2022) and align with known prognostic factors (stage, KPS, tumor size). This provides face validity for clinical utility.
- **Handles general right-censored data**: Unlike Candès et al. (2023) and Gui et al. (2024), which require observed censoring times (Type-I setting), the proposed method works for general right-censored data where only min(T, C) and the event indicator are observed — the more common practical scenario.

## Weaknesses

### Fatal
None

### Major
- **Gap between theoretical guarantee (fixed τ) and practical procedure (optimized τ)**: Theorem 4.1 provides coverage guarantees for a fixed quantile level τ. However, the practical procedure (Section 4.1, "LPB optimization") selects τ*(x) = argmax_τ [q̂_τ(x) − c_{1−α}(τ)(x)] to maximize the LPB per test point. Since maximizing the lower bound tightens it, this optimization can only decrease coverage and never increase it. The paper states "our procedure yields a prediction set that satisfies the coverage guarantee for any τ ∈ (0, 1)" (line 162) and then immediately optimizes over τ without proving this preserves coverage. Table 1 reports empirical coverage for the optimized τ* but with only 10 trials and on a single setting — this is insufficient empirical evidence to bridge the theoretical gap. The paper should either prove sufficient conditions under which optimization preserves coverage, present fixed-τ (τ=α) results as the primary result and treat τ-optimization as a heuristic extension, or explicitly bound the coverage loss from optimization.
- **"Exact coverage" framing overstates the practical guarantee**: The paper repeatedly positions its contribution as providing "exact marginal coverage" in contrast to "PAC-type guarantees" (abstract, Section 1, Section 3). However, Theorem 4.1 shows P(T(w) ≥ L̃(X)) ≥ 1 − α − (1/2) E[|ω̃(X) − ω(X)|], which includes an explicit error term depending on weight estimation quality (estimated via Random Forest). The guarantee is "exact" only when ω is known exactly. The asymptotic guarantee (Theorem 4.2) requires additional technical conditions A2(i)–(ii). While this is a genuine improvement over PAC-type bounds, the paper should be more precise about when "exact" applies versus when it is approximate, since the distinction matters for the paper's positioning relative to prior work.

### Minor
- **"Relative LPB" metric not formally defined in main text**: The experimental results use "Relative LPB" as a primary evaluation metric across Figures 1–3, but its definition does not appear in the main text. The varying scales across figures (0.7–1.1 in Figure 1 vs. 1.0–2.5 in Figure 2) suggest different normalizations, making cross-figure comparison difficult without the definition.
- **Small effective sample sizes for real data**: With 541 patients split across 4 treatment groups and further into train/calibration/test (50%/10%/30%/10% per Figure 1 caption), the effective calibration sample sizes per treatment are small. The paper should report per-group sample sizes and discuss whether the asymptotic guarantees are reliable at these scales.

### Trivial
None

## Nice-to-Haves
- Empirical estimates of E[|ω̃(X) − ω(X)|] would help readers understand how much of the gap between PAC and exact guarantees is closed in practice.
- A sensitivity analysis to the proportion of censored observations in the calibration set would be valuable, since the effective calibration sample size can become very small under high censoring.
- Discussing when conditions A2(i) and A2(ii) of Theorem 4.2 are expected to hold in common survival models would strengthen the paper.
- The paper only considers binary treatments; mentioning the multi-treatment limitation more prominently would improve transparency.

## Removed Points
These points are flagged to be removed, treat them with caution.
- "Assumption 3.1 is strong" — Standard in causal survival analysis; the paper acknowledges it in Remark 3.2 and Discussion. Criticizing standard assumptions is scope creep.
- "Relative LPB definition absent" — Likely in the appendix, which is stripped by the parser.
- Criticisms about notation inconsistencies (ω̂ vs ω̃, T̂ vs L̃) — These appear to be parser artifacts, not paper issues.
- "Binary treatment limitation" — This is stated in the paper and the extension is mentioned; it's a scope choice, not a flaw.

## Novel Insights
The key novel insight from the review process is the identification of the τ-optimization gap: the paper's theory guarantees coverage for fixed τ, but the practical algorithm optimizes over τ in a way that can only decrease coverage, and this discrepancy is neither proven nor explicitly acknowledged. This is a genuine structural issue that the authors should address, as it affects the relationship between the theoretical guarantee and the deployed algorithm. The distinction between "exact" coverage (when weights are known) and "approximate exact" coverage (with estimated weights) is also an important nuance for the field's understanding of conformal prediction guarantees.

## Suggestions
- Either prove sufficient conditions under which τ-optimization preserves coverage (e.g., if L̃(x, τ) is concave in τ with certain uniform bounds on non-conformity scores), or present fixed-τ (τ=α) results as the primary result with τ-optimization as a heuristic extension.
- Provide empirical estimates of the weight estimation error E[|ω̃(X) − ω(X)|] across experimental settings to quantify the gap between theoretical and practical guarantees.
- Add "Relative LPB" definition to the main text for interpretability of experimental results.
- Report per-group sample sizes for the real data experiments and discuss reliability of asymptotic guarantees at these scales.

## Reporting

**All retrieved anchor papers across rounds:**

| Path | Avg Score | Round | Comparison |
|------|-----------|-------|------------|
| Uj0h13lVrR.md | 1.00 | R1 | Unrelated (GFlowNets); low-quality reject |
| 5lUdTogEL3.md | 1.00 | R1 | Unrelated (person re-ID); low-quality reject |
| P49gSPmrvN.md | 1.00 | R1 | Unrelated (UMAP visualization); low-quality reject |
| bEgDEyy2Yk.md | 1.00 | R1 | Unrelated (graph algorithms); low-quality reject |
| y2ch7iQSJu.md | 2.00 | R1 | Weak survival paper; much lower quality than submission |
| v8RDgaEtE2.md | 2.50 | R1 | CP regression under bias; rejected, weaker contribution |
| aoW5Sm8Op8.md | 2.33 | R1 | Survival benchmarking; rejected, weaker |
| 7HdtLgsvys.md | 2.50 | R1 | Tube loss for PI estimation; rejected, weaker |
| uUkpYafkVl.md | 4.75 | R1 | CP for classifiers; rejected, unrelated domain |
| Dtxc7mlKRg.md | 4.60 | R1 | Class-conditional CP for imbalanced data; rejected |
| RcNzwKrjTo.md | 5.00 | R1 | CP for improved conditional coverage; rejected |
| XgYPzNtz0s.md | 4.60 | R1 | Survival via density estimation; rejected, much weaker |
| JQtuCumAFD.md | 5.50 | R1 | **Closest prior work** (Davidov et al.); ACCEPTED with PAC-type guarantee. Submission directly improves upon this. |
| pVL4bYKOGM.md | 5.50 | R1 | CP for causal effects of continuous treatments; REJECTED, weak evaluation |
| AKAz88zYLB.md | 5.80 | R1 | CP for dose-response; REJECTED, conservative intervals |
| Nfd7z9d6Bb.md | 6.00 | R1 | Probabilistic CP with approximate conditional validity; ACCEPTED |
| rulxyXjf46.md | 6.25 | R1 | CP via regression-as-classification; ACCEPTED |
| 33XGfHLtZg.md | 7.00 | R1 | Conformal Risk Control; ACCEPTED, foundational work |
| A3YUPeJTNR.md | 8.00 | R1 | Unrelated (prediction timing); high-quality accept |
| EUSkm2sVJ6.md | 7.60 | R1 | Unrelated (dataset usage inference); high-quality accept |
| xByvdb3DCm.md | 8.00 | R2 | Causal discovery with selection bias; topically distant |
| 3cuJwmPxXj.md | 8.00 | R2 | Intervention extrapolation; topically distant |

**Round 1 bracket: 6.0–7.0.** The paper clearly improves upon JQtuCumAFD (5.50, accepted) with a stronger guarantee and better robustness, placing it above 5.50. It's comparable to Nfd7z9d6Bb (6.00, accepted) in contribution level but with a more concrete improvement over prior work. The τ-optimization gap holds it back from 7.0 (the Conformal Risk Control level).

**Final score: 6.5** — The paper makes a genuine and well-supported theoretical advance over the accepted prior work in the same area (exact vs. PAC guarantees, doubly robust property), with solid empirical validation including outlier robustness and real clinical data. The τ-optimization gap and overstated "exact coverage" framing are real weaknesses that prevent a higher score but do not undermine the core contribution.

MY FINAL SCORE: <score>6.5</score>
MY FINAL DECISION: <score>Accept</score>